General Range
CEFENORM 200
Price on request/100 · MOQ 100 boxes
CEFENORM 200 Tablets by Enormmed Pharma Private Limited contain Cefpodoxime Proxetil 200 mg, a third-generation cephalosporin antibiotic prescribed for the treatment of certain bacterial infections caused by susceptible microorganisms.
Cefpodoxime Proxetil is an oral antibiotic that converts into its active form, Cefpodoxime, after absorption. It works by inhibiting bacterial cell wall synthesis, helping eliminate susceptible bacteria responsible for various infections.
CEFENORM 200 Tablets may be prescribed for bacterial respiratory tract infections, throat and tonsil infections, sinusitis, middle ear infections, urinary tract infections, and certain skin and soft tissue infections. Its use depends on the type of infection and bacterial susceptibility.
The dispersible tablet formulation provides an alternative method of administration when appropriate. The dosage, preparation method and duration of treatment should be determined by a registered medical practitioner.
CategoryGeneral Range
Min. Order100 boxes
Supplied byEnorm Med Pharma Pvt. Ltd.
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefpodoxime Proxetil Dispersible Tablets
- Packaging Type
- Dispersible Tablets
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Treatment of selected cases of community-acquired bacterial pneumonia.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Enorm Med Pharma Pvt. Ltd.Panchkula, Haryana
Enorm Med Pharma Private Limited is an Indian pharmaceutical company based in Panchkula, Haryana, specializing in the manufacture, trade, wholesale, and export of a wide range of pharmaceutical formulations.
Company Overview
• Incorporation / Establishment: Originally started as a proprietorship in 2021, later incorporated as a private limited company on April 9, 2023 (CIN: U46497HR2023PTC110540).
• Registered Address: SCO 272, Sector-20, Panchkula, Haryana – 134116, India.
• Directors / Leadership: Sukhinder Jindal and Gurpreet Jindal.
• Certifications: ISO 9001:2015 and WHO-GMP compliant operations/standards.
• Business Model: PCD (Propaganda Cum Distribution) Pharma Franchise, third-party manufacturing, wholesale distribution, and domestic/global supply.
Product Portfolio
Enorm Med Pharma deals in diverse therapeutic segments and dosage forms, including:
• Dosage Forms: Tablets, capsules, softgelatin capsules, syrups, dry syrups, injections (vials), and ointments.
• Therapeutic Ranges: Anti-infectives, cardiac, diabetic, dermatology, and general wellness/herbal formulas.
• Notable Branded Products: Azeenorm (Azithromycin), Diclonorm, Enomzole-D, Levonorm, Pantenorm, Norsunate (Artesunate injections), and Mebenorm.
More General Range
